Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
177M
-
Number of holders
-
207
-
Total 13F shares, excl. options
-
188M
-
Shares change
-
+30.8M
-
Total reported value, excl. options
-
$2.19B
-
Value change
-
+$369M
-
Put/Call ratio
-
0.64
-
Number of buys
-
116
-
Number of sells
-
-75
-
Price
-
$11.69
Significant Holders of OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) as of Q3 2025
239 filings reported holding OCUL - OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share as of Q3 2025.
OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) has 207 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 188M shares
.
Largest 10 shareholders include FMR LLC (31.8M shares), VR ADVISER, LLC (13.2M shares), Summer Road LLC (12.6M shares), Deep Track Capital, LP (11.9M shares), BlackRock, Inc. (10.6M shares), Avoro Capital Advisors LLC (10.3M shares), VANGUARD GROUP INC (9.16M shares), TCG Crossover Management, LLC (6.12M shares), CITADEL ADVISORS LLC (5.7M shares), and Point72 Asset Management, L.P. (4.6M shares).
This table shows the top 207 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.